Showing results (211-220 of 262) with videos related to

Sort By:
Pageof 27
Cancer Research|August 1, 1988
Acodazole hydrochloride: phase I trial, pharmacokinetics, and evaluation of cardiotoxicity in dogsR Pazdur, G G Chabot, C A Campbell, et al.
American Journal of Clinical Oncology|February 1, 1983
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lungV Ratanatharathorn, M K Samson, C D Haas, et al.
Cancer|March 4, 2000
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group StudyS K Williamson, D Lew, G J Miller, et al.
American Journal of Clinical Oncology|August 1, 1993
Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group studyE H Kraut, T Fleming, J S Macdonald, et al.
Cancer|January 15, 1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group studyR M Bukowski, T R Fleming, J S Macdonald, et al.
Investigational New Drugs|February 1, 1991
Crisnatol mesylate: phase I dose escalation by extending infusion durationE A Poplin, G G Chabot, R L Tuttle, et al.
Cancer|October 15, 1991
A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancerG T Budd, S Green, L H Baker, et al.
Cancer Treatment Reports|October 1, 1978
Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestineR J Fraile, M K Samson, T R Buroker, et al.
Investigational New Drugs|January 1, 1983
Phase I trial of aclacinomycin-A. A clinical and pharmacokinetic studyC Karanes, J D Young, M K Samson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapyY Sugawara, S J Fisher, K R Zasadny, et al.
Pageof 27